Scholtes, Rosalie A.
Muskiet, Marcel H.A. http://orcid.org/0000-0003-4116-555X
van Baar, Michiel J.B.
Hesp, Anne C.
Greasley, Peter J.
Karlsson, Cecilia
Hammarstedt, Ann
Arya, Niki
van Raalte, Daniƫl H.
Heerspink, Hiddo J.L. http://orcid.org/0000-0002-3126-3730
Clinical trials referenced in this document:
Documents that mention this clinical trial
Natriuretic Effect of Two Weeks of Dapagliflozin Treatment in Patients With Type 2 Diabetes and Preserved Kidney Function During Standardized Sodium Intake: Results of the DAPASALT Trial (Results)
https://doi.org/10.2337/dc20-2604
Reduction of Cardiovascular Risk and Improved Estimated Glomerular Filtration Rate by SGLT2 Inhibitors, Including Dapagliflozin, Is Consistent Across the Class: An Analysis of the Placebo Arm of EXSCEL
https://doi.org/10.2337/dc18-1871
Funding for this research was provided by:
AstraZeneca